Cronos Group is executing a successful turnaround, evidenced by record Q2 2026 revenue of $70.6M (up 111% YoY) and a gross margin expansion to 40.3% from 17.7% in Q4 2025. The company's fortress balance sheet, with $467M cash and zero debt, provides strategic ...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $0.09+800.0% vs $0.01 | $53M+19.9% vs $44M |
Q2 2026 May 11, 2026 | $0.04+700.0% vs $0.01 | $45M+7.1% vs $42M |
Q1 2026 Feb 26, 2026 | -$0.00-147.0% vs $0.01 | $45M+15.0% vs $39M |
Q4 2025 Nov 6, 2025 | $0.07+250.0% vs $0.02 | $36M-2.6% vs $37M |
Cronos Group Inc. is upgraded to a Buy, driven by a best-in-class balance sheet and improved profitability. CRON boasts $827 million in cash, no debt, and strong international expansion, with adjusted gross margins reaching 46%. Profitability is supported by disciplined cost management and positive GAAP operating profit, distinguishing CRON from Canadian peers.
Registration is now open for Cronos' first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026 Registration is now open for Cronos' first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026
Here is how Cronos Group (CRON) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.
TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted multipack, featuring its first live resin gummy. This month the brand will also launch new flavors in its best-selling lineup of vape cartridges, Strawberry Banana and Sweet Citrus Punch.
Benchmark CRON against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Cronos Group Inc. (CRON)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.40 | $1.27B | -135.46 | 26.81% | -6.44% | -0.85% | — | |
| $0.94 | $394.99M | -1.50 | 5.8% | -80.67% | -32.79% | — | |
| $4.11 | $459.63M | -3.77 | -18.77% | -12.9% | -8.09% | — | |
| $4.22 | $261.4M | -2.78 | -6.61% | -38.15% | -20.36% | — | |
| $55.28 | $1.6B | 14.07 | -13.8% | 52.27% | 7.39% | — | |
| $52.83 | $3.07B | 21.39 | -3.93% | 2.19% | — | — |
Cronos Group Inc. (CRON) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Cronos Group Inc. (CRON) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
Jun 22, 2026·SEC
May 11, 2026·SEC
Get notified when CRON posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Cronos Group Inc. (CRON) stock FAQ — growth, dividends, profitability & financials explained
Cronos Group Inc. (CRON) reported $242.8M in revenue for fiscal year 2025.
Cronos Group Inc. (CRON) grew revenue by 26.8% over the past year. This is strong growth.
Yes, Cronos Group Inc. (CRON) is profitable, generating $69.8M in net income for fiscal year 2025 (-6.4% net margin).
Cronos Group Inc. (CRON) has a return on equity (ROE) of -0.9%. Negative ROE indicates the company is unprofitable.
Cronos Group Inc. (CRON) generated $44.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
